• No results found

[PDF] Top 20 Outcome and Human Epithelial Growth Factor Receptor (HER) 1 4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling

Has 10000 "Outcome and Human Epithelial Growth Factor Receptor (HER) 1 4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling" found on our website. Below are the top 20 most common "Outcome and Human Epithelial Growth Factor Receptor (HER) 1 4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling".

Outcome and Human Epithelial Growth Factor Receptor (HER) 1 4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling

Outcome and Human Epithelial Growth Factor Receptor (HER) 1 4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling

... Eighty-nine patients who had a breast cancer more than 2 cm in diameter were recruited in the original study between 1989 and 1992. This size criterion was used to ensure that adequate tissue was available for analysis ... See full document

6

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy

... Thymic epithelial tumors, TC; thymic carcinomas, VEGF-A; Vascular endothelial growth factor-A, VEGFR1; Vascular endothelial growth factor receptor 1, VEGFR2; Vascular endothelial ... See full document

11

Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter retrospective study

Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter retrospective study

... binds human epidermal growth factor receptor 2 (HER2), dramatically improves the clinical outcomes of HER2- positive breast ...hormone receptor (HR) ... See full document

12

PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

... In patients randomized to the control arm, we did not observe an association between PIK3CA mutations, or any of the other tested molecular aberrations, and breast cancer prognosis, when corrected for known prognostic ... See full document

10

Nuclear Klf4 accumulation is associated with cetuximab drug resistance and predicts poor prognosis of nasopharyngeal carcinoma

Nuclear Klf4 accumulation is associated with cetuximab drug resistance and predicts poor prognosis of nasopharyngeal carcinoma

... Kruppel-like factor 4; cKlf4: cytoplasm Kruppel-like factor 4; nKlf4: nuclear Kruppel-like factor 4; EGFR: epithelial growth factor receptor; nEGFR: nuclear ... See full document

13

Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma

Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma

... inflammatory factor secreted by TAMs in ...tumor growth and survival, as well as increased tumor invasion, migration and ...both human HCC cell lines and mouse models have shown that IL-8 also ... See full document

13

Upregulation of cell surface mucin MUC15 in human nasal epithelial cells upon influenza A virus infection

Upregulation of cell surface mucin MUC15 in human nasal epithelial cells upon influenza A virus infection

... UK), epithelial growth factor receptor (EGFR) (1:2000 dilution, Abcam), phospho-ERK (1:1000 dilution, Cell Signaling Technology), ERK (1:1000 dilution, Cell Signaling Technol- ogy), ... See full document

11

The coexpression  and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study

The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study

... fibroblast growth factor receptor 2 (FGFR2), and human epidermal growth factor receptor 2 (HER2) in human GC and their clinical significance in clinical therapy ... See full document

11

Upregulated  epidermal growth factor receptor expression following near-infrared irradiation simulating solar radiation in a three-dimensional reconstructed human corneal epithelial tissue culture model

Upregulated epidermal growth factor receptor expression following near-infrared irradiation simulating solar radiation in a three-dimensional reconstructed human corneal epithelial tissue culture model

... corneal epithelial cells was extracted in QIAzol reagent (Qiagen NV, Venlo, the Netherlands) and spin-column purified using a RNeasy mini spin column (Qiagen ...reconstructed human corneal epithelial ... See full document

7

Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic target

Human epithelial growth factor receptor 2 in human salivary carcinoma ex pleomorphic adenoma: a potential therapeutic target

... The human fibroblast HS683 cell line was purchased from the American Type Culture Collection. All cell lines were preserved by the Shanghai Key Laboratory of Stomatology, the Ninth People’s Hospital, Shanghai Jiao ... See full document

9

Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo adjuvant chemotherapy in patients with triple negative breast cancer

Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo adjuvant chemotherapy in patients with triple negative breast cancer

... and human epidermal receptor 2 (HER2)-overexpressing subgroups are the shortest ...estrogen receptor (ER) and progesterone receptor (PR) as well as HER2 ... See full document

7

Human Trophoblast Progenitor Cells Express and Release Angiogenic Factors

Human Trophoblast Progenitor Cells Express and Release Angiogenic Factors

... (13).Additionally, human placenta-derived MSC-like cells were shown to be present in blood flow, and promote collateral vessel formation in the injured limb upon increased M2-like macrophages accumulation in ... See full document

9

6100.pdf

6100.pdf

... EGFR(epidermal growth factor receptor) and the related HER-2 (human epidermal growth factor receptor 2) associated with breast cancer has allowed for the development of ... See full document

46

Key signalling nodes in mammary gland development and cancer  Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts

Key signalling nodes in mammary gland development and cancer Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts

... by growth factor RTKs (receptor tyrosine kinases) such as insulin receptor, insulin-like growth factor receptor (IGF-1R), platelet-derived growth factor ... See full document

9

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

... EGFR was the first tyrosine kinase receptor to be directly linked with human cancer. The EGFR gene maps to 7p11.2- p2 and encodes a 170 kDa transmembrane protein [1]. EGFR gene amplification has been ... See full document

8

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers

... the receptor for insulin (class II), for PDGF (Class III), for FGF (class IV), for VEGF (class V) and HGF (MET, Class VI) are strongly associated with oncological ... See full document

12

Insulin-Like Growth Factor I Receptor (IGF-IR) Ligands and BMI in Squamous Intra-Epithelial Lesion (SIL) of Cervix

Click here to download PDF version of the article !

... insulin-like growth factor-I & -II (IGF-I & IGF-II) and insulin- like growth factor binding protein-3 (IGFBP-3) with pathogenesis of cervical ...including growth, proliferation ... See full document

5

Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity

Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity

... transforming growth factor β1 (TGF-β1) and its receptors [33-36], hepatocyte growth factor (HGF) and its receptor (cMet) [37-39, 45], platelet derived growth factor (PDGF) ... See full document

19

Metastasizing Maxillary Ameloblastoma: Report of a Case with Molecular Characterization

Metastasizing Maxillary Ameloblastoma: Report of a Case with Molecular Characterization

... BRAF is a potent activator of the mitogen activated protein kinase (MAPK) cascade, which in turn phosphorylate and activate extracellular signal- regulated kinases 1 and 2 (ERK1/ERK2) [16,17]. ERK regulates the ... See full document

7

The progress of targeted therapy in advanced gastric cancer

The progress of targeted therapy in advanced gastric cancer

... HER2: Human epidermal growth factor receptor-2; EGFR: Epidermal growth factor receptor; VEGF: Vascular endothelial growth factor; HGF: Hepatocyte ... See full document

8

Show all 10000 documents...